Abstract

Introduction: Determining stroke etiology is paramount to clinical management and prevention of recurrent strokes. Although stroke patients undergo extensive post-treatment work-ups, 30-40% of cases remain cryptogenic. Hypothesis: Engineered histomic features from digital pathology images of stroke blood clots collected during mechanical thrombectomy (MT) can be used to delineate stroke etiology. Methods: For clots retrieved from patients undergoing MT, etiology was determined by the trial of Trial of Org 10172 in Acute Stroke Treatment (TOAST) score. After sectioning and H&E staining, clot components (red blood cells-RBCs, fibrin-platelet regions-FP, and white blood cells-WBCs) were segmented from whole slide images. Histomic features were engineered to capture the structural distribution of RBC/FP regions throughout the clot. To measure clot WBC diversity, WBC instances were clustered into WBC “classes” based on texture, and summarized as a class frequency distribution (CFD). The three most significant RBC/FP and WBC features between large artery atherosclerosis (LAA) and cardioembolic (CE) cases were used to train a complement Naïve Bayes (CNB) model, which was then implemented to predict the etiology of cryptogenic cases. Results: In our data (n=53), 31 clots were CE, 8 were LAA, 4 were from strokes of other determined etiology, and 10 were cryptogenic. 17 significant RBC/FP features and 3 significant WBC CFDs were different between CE and LAA. The trained CNB model accurately classified CE vs. LAA with a validation AUC of 0.87±0.03, exhibiting superior performance to a model trained using common clot percent cellular composition metrics (AUC=0.69±0.16). Furthermore, we showed the potential to classify cryptogenic cases as CE or LAA. Conclusions: This first-of-its-kind, biologically-informed clot histomic pipeline captured significant information that may augment clinical and laboratory features used in stroke etiology classification.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.